<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) inhibits insulin action, in part, by activating c-jun NH(2)-terminal kinases (JNK) </plain></SENT>
<SENT sid="1" pm="."><plain>However, the precise mechanisms by which TNF-alpha activates JNK are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, we confirmed that <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> increased <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> reactive oxygen species (ROS) production, and which can associate with the pathogenesis of <z:e sem="disease" ids="C0011875" disease_type="Disease or Syndrome" abbrv="">diabetic vascular complications</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> signal-regulating kinase 1 (ASK1) was reported to activate the JNK and p38 signaling pathways and is required for TNF-alpha-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Here we demonstrate that TNF-alpha increases <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> ROS production and ASK1 activity, and that these TNF-alpha-induced phenomena associate with JNK activation, increase in Ser(307) phosphorylation of IRS-1 and decrease in insulin-stimulated tyrosine phosphorylation of IRS-1, <z:hpo ids='HP_0000001'>all</z:hpo> of which are believed to be the molecular basis of TNF-alpha-induced <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>We claim that <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> ROS production may be a key factor not only in <z:e sem="disease" ids="C0011875" disease_type="Disease or Syndrome" abbrv="">diabetic vascular complications</z:e>, but also in the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>This integrating paradigm could provide a new conceptual framework for further research and therapies for the treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>